Search results
The race for a weight loss pill heats up as a Novo Nordisk competitor releases new trial results
Quartz· 2 days agoIt’s the latest development in the race among several pharmaceutical companies to introduce new ...
Structure Therapeutics (GPCR) Stock Soars 60% on Weight Loss Drug Success
InvestorPlace· 1 day agoStructure Therapeutics (NASDAQ:GPCR) stock is surging today, up 60% after the biotech company...
Weight loss drugs like Ozempic might also make your taste buds better
Quartz· 2 days agoSemaglutide, the active ingredient in popular diabetes and obesity drugs Ozempic and Wegovy, can...
7 Best Fiber Supplements for Weight Loss, According to Dietitians — Best Life
Best Life· 7 days agoThis essential nutrient helps with overall well-being, keeping you fuller for longer, supporting...
Structure Therapeutics reports promising weight-loss drug data | Invezz
Invezz· 1 day agoStructure Therapeutics Inc (NASDAQ: GPCR) is up a whopping 80% on Monday after reporting “compelling” topline data for its weight-loss drug. The biopharmaceutical ...
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.
Motley Fool via Yahoo Finance· 2 days agoThat puts its efficacy at roughly...Viking additionally has another clinical-stage program testing...
William Blair Commentary: Waistlines and GLP1-s--Expanding in Unison
GuruFocus.com via Yahoo Finance· 13 hours agoGiven the significant TAM of GLP-1 medications, we expect there...Novo Nordisk and retatrutide from...
Structure Therapeutics Stock Soars on Obesity Pill Data
The Wall Street Journal· 2 days agoStructure’s once-daily drug, code-named GSBR-1290, helped people lose an average of more than 6% of...
Shape's Dietary Supplement Methodology
Shape via Yahoo News· 10 hours agoWhat We Don't Recommend We don’t recommend potentially dangerous products (beyond the typical risks associated with nutritional supplements), or those...
This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors
Motley Fool via Yahoo Finance· 4 days agoNovo Nordisk and Eli Lilly are the early leaders in the GLP-1 weight loss market, but that may not...
